State Board Of Administration Of Florida Retirement System Eagle Pharmaceuticals, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$41.26 - $51.35 $296,783 - $369,360	-7,193 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$45.82 - $56.9 $41,054 - $50,982	-896 Reduced 11.08%	7,193 $366,000
Q2 2021 Aug 10, 2021	BUY	$36.86 - $44.5 $24,106 - $29,103	654 Added 8.8%	8,089 $346,000
Q1 2021 May 10, 2021	SELL	$40.32 - $50.97 $945,705 - $1.2 Million	-23,455 Reduced 75.93%	7,435 $310,000
Q4 2020 Feb 08, 2021	SELL	$41.72 - $51.34 $4,589 - $5,647	-110 Reduced 0.35%	30,890 $1.44 Million
Q3 2020 Nov 09, 2020	SELL	$37.02 - $51.28 $79,889 - $110,662	-2,158 Reduced 6.51%	31,000 $1.32 Million
Q2 2020 Aug 07, 2020	SELL	$43.24 - $55.02 $189,131 - $240,657	-4,374 Reduced 11.65%	33,158 $1.59 Million
Q1 2020 May 05, 2020	BUY	$34.37 - $60.07 $27,908 - $48,776	812 Added 2.21%	37,532 $1.73 Million
Q4 2019 Feb 03, 2020	BUY	$54.32 - $64.31 $1.26 Million - $1.49 Million	23,159 Added 170.78%	36,720 $2.21 Million
Q3 2019 Nov 07, 2019	BUY	$53.25 - $59.98 $308,637 - $347,644	5,796 Added 74.64%	13,561 $767,000
Q2 2019 Aug 05, 2019	BUY	$46.61 - $58.45 $5,593 - $7,014	120 Added 1.57%	7,765 $432,000
Q1 2019 May 03, 2019	SELL	$38.66 - $51.82 $5,412 - $7,254	-140 Reduced 1.8%	7,645 $386,000
Q2 2018 Aug 06, 2018	BUY	$51.25 - $76.62 $127,100 - $190,017	2,480 Added 46.75%	7,785 $589,000
Q3 2017 Oct 31, 2017	BUY	$46.62 - $60.36 $247,319 - $320,209	5,305	5,305 $316,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account